- Product Namedifferent colours
- Supply TypeDistributor
- Preferred Buyer Location All over the world
Alectinib is an oral drug that blocks the activity of anaplastic lymphoma kinase and is used to treat non-small-cell lung cancer. It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group.
View More Details